Table 2.

Recurrent CNAs and CN-LOHs in T-LLy with the incidence in ETP and non-ETP cases along with the genomic coordinates

ChromosomeCasesIncidence in ETP-LLyIncidence in Non-ETP T-LLyP value (ETP vs non ETP)Minimal common regionStart genomic coordinatesStop genomic coordinatesAffected genes
Recurrent gains 
 6 5, 15 0/9 2/15 .511 6q23.3 135c483,742 135c754,471 MYB 
 9 11, 23 1/9 1/15 1.000 9q34.12q34.13 133c719,421 134c094,802 NUP14-ABL1 
Recurrent losses 
 1 19, 22, 23, 24 4/9 0/15 .012* 1p36.32p36.31 3c921c449 7c050c061 RPL11 
 12 19, 20, 22 3/9 0/15 .042* 12p12.3 17c200,436 18c268,880 RERGL 
 13 6, 11 0/9 2/15 .511 13q14.2 48c984,722 49c065,037 RB1 
 4 14, 15 0/9 2/15 .511 4q12 54c324,930 55c102,425 FIP1L1, CHIC, PDGFRa 
 X 11, 23 1/9 1/15 1.000 Xq26.2q26.3 130c973,820 134c242,874 PHF6 
Recurrent LOHs 
 4 8, 15 0/9 2/15 .511 4q28.1q35.2 126c144,980 191c154,276 FBXW7 
Recurrent losses and/or LOHs 
 9 1-11, 13-15, 17, 21, 22, 24 4/9 14/15 .015* 9p21.3 21c901,263 21c993,468 CDKN2A, CDKN2B 
ChromosomeCasesIncidence in ETP-LLyIncidence in Non-ETP T-LLyP value (ETP vs non ETP)Minimal common regionStart genomic coordinatesStop genomic coordinatesAffected genes
Recurrent gains 
 6 5, 15 0/9 2/15 .511 6q23.3 135c483,742 135c754,471 MYB 
 9 11, 23 1/9 1/15 1.000 9q34.12q34.13 133c719,421 134c094,802 NUP14-ABL1 
Recurrent losses 
 1 19, 22, 23, 24 4/9 0/15 .012* 1p36.32p36.31 3c921c449 7c050c061 RPL11 
 12 19, 20, 22 3/9 0/15 .042* 12p12.3 17c200,436 18c268,880 RERGL 
 13 6, 11 0/9 2/15 .511 13q14.2 48c984,722 49c065,037 RB1 
 4 14, 15 0/9 2/15 .511 4q12 54c324,930 55c102,425 FIP1L1, CHIC, PDGFRa 
 X 11, 23 1/9 1/15 1.000 Xq26.2q26.3 130c973,820 134c242,874 PHF6 
Recurrent LOHs 
 4 8, 15 0/9 2/15 .511 4q28.1q35.2 126c144,980 191c154,276 FBXW7 
Recurrent losses and/or LOHs 
 9 1-11, 13-15, 17, 21, 22, 24 4/9 14/15 .015* 9p21.3 21c901,263 21c993,468 CDKN2A, CDKN2B 

Cases 1-15 are non-ETP T-LLy, and cases 16-24 are ETP-LLy.

*

P < .05. 

Close Modal

or Create an Account

Close Modal
Close Modal